Paul K. Audhya, CHIEF MEDICAL OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 10,592 shares at $13.45 ($142K) on 2025-11-24, disclosed to the SEC on 2025-11-26.
Seasonal sale ($142k) by CHIEF MEDICAL OFFICER — this insider has traded KALV in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.45 | 5,296 | $71K | 50.0% |
| 2 | $13.45 | 5,296 | $71K | 50.0% |
| Total | $13.45 avg | 10,592 | $142K | 100% |
| Filing → |
| KALV | SELL | 2026-05-19 | $28K | — | Filing → |
| KALV | SELL | 2026-04-20 | $54K | — | Filing → |
| KALV | SELL | 2026-02-24 | $167K | — | Filing → |